Lv41
676 积分 2022-11-14 加入
The response to anti–PD-1 and anti–LAG-3 checkpoint blockade is associated with regulatory T cell reprogramming
1小时前
待确认
Upregulation of PIK3IP1 monitors the anti-cancer activity of PI3Kα inhibitors in gastric cancer cells
7天前
已完结
PIK3IP1: structure, aberration, function, and regulation in diseases
9天前
已完结
CD45: new jobs for an old acquaintance
29天前
已完结
Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy
1个月前
已完结
Lymph-node-derived stem-like but not tumor-tissue-resident CD8+ T cells fuel anticancer immunity
1个月前
已完结
Regulators of CD8+ T cell exhaustion
2个月前
已完结
Basiliximab for IL‐2‐Associated Inflammatory Disorder With Atopic Dermatitis
2个月前
已完结
Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma
2个月前
已完结
PD‐1‐Cis IL‐2R Agonism Determines the Predicted Pharmacological Dose Range for the Immunocytokine Eciskafusp Alfa (PD1‐IL2v)
3个月前
已完结
Lactate dehydrogenase A: a potential new target for tumor drug resistance intervention
皖公网安备34019202002308
